Che-hung Lin

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia.

Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia.

Journal: Cancers

Published: January 29, 2024

Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.

Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.

Journal: Anticancer research

Published: October 02, 2023

Re-evaluating the role of pelvic radiation in the age of modern precision medicine and systemic therapy.

Re-evaluating the role of pelvic radiation in the age of modern precision medicine and systemic therapy.

Journal: World journal of clinical oncology

Published: September 25, 2023

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective Study.

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone-A Retrospective Study.

Journal: Cancers

Published: June 11, 2023

Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study.

Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study.

Journal: Anticancer research

Published: January 30, 2023

Chondrosarcoma of Ureter in an Elderly Patient: A Case Report.

Chondrosarcoma of Ureter in an Elderly Patient: A Case Report.

Journal: Medicina (Kaunas, Lithuania)

Published: January 27, 2023

Combination of Durvalumab and Chemotherapy to Potentially Convert Unresectable Stage IV Penile Squamous Cell Carcinoma to Resectable Disease: A Case Report.

Combination of Durvalumab and Chemotherapy to Potentially Convert Unresectable Stage IV Penile Squamous Cell Carcinoma to Resectable Disease: A Case Report.

Journal: Current oncology (Toronto, Ont.)

Published: November 29, 2022

Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.

Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.

Journal: International journal of hematology

Published: July 05, 2021

Bilateral lacrimal glands and paranasal sinus diffuse large B-cell lymphoma following lung mucosa-associated lymphoid tissue lymphoma in one patient.

Bilateral lacrimal glands and paranasal sinus diffuse large B-cell lymphoma following lung mucosa-associated lymphoid tissue lymphoma in one patient.

Journal: Taiwan journal of ophthalmology

Published: September 01, 2020

A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.

A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.

Journal: Anticancer research

Published: July 15, 2016

Intensity-Modulated Radiotherapy in Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer.

Intensity-Modulated Radiotherapy in Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer.

Journal: Diseases of the colon and rectum

Published: May 05, 2016

Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome.

Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome.

Journal: Annals of hematology

Published: February 23, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026